Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteersSTEAD, Richard B; LAMBERT, John; WESSELS, Dawie et al.Blood. 2006, Vol 108, Num 6, pp 1830-1834, issn 0006-4971, 5 p.Article

Peginesatide in Patients with Anemia Undergoing HemodialysisFISHBANE, Steven; SCHILLER, Brigitte; MAYO, Martha R et al.The New England journal of medicine. 2013, Vol 368, Num 4, pp 307-319, issn 0028-4793, 13 p.Article

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4⁺ T cellsDE BOER, Alberdina W; MARKOWITZ, Norman; LANE, H. Clifford et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 106, Num 3, pp 188-196, issn 1521-6616, 9 p.Article

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120 : A phase 2 study in higher- and lower-risk volunteersBELSHE, Robert B; STEVENS, Cladd; FLORES, Jorge et al.The Journal of infectious diseases. 2001, Vol 183, Num 9, pp 1343-1352, issn 0022-1899Article